Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein M pseudogene 1 (HNRNPMP1) is classified as a pseudogene in the human genome. Pseudogenes are DNA sequences similar to known genes, but have lost their protein-coding ability or are otherwise non-functional in the classical sense. HNRNPMP1 does not encode an active heterogeneous nuclear ribonucleoprotein M protein and is not considered a receptor, enzyme, or therapeutic target. It lacks known biological activity, disease association, drug interactions, or safety concerns and is not used scientifically as a biomarker or in clinical applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein M pseudogene 1 (HNRNPMP1).